Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Galapagos announces proof-of-mechanism milestone in alliance with GSK

Dec. 21, 2011

Treatment begins in phase III Benlysta trial

Dec. 19, 2011

Arcarios receives loan to develop osteoarthritis drug candidate

Dec. 14, 2011

Novel immunomodulating and anti-inflammatory compounds described

Dec. 9, 2011

Scientists at Merck & Co. synthesize new fatty-acid amide hydrolase inhibitors

Dec. 7, 2011

Sanofi recruits patients in phase I/II trial of SAR-113945

Dec. 5, 2011

Auxilium Pharmaceuticals doses first patient in Xiaflex study

Dec. 2, 2011

Ablynx's phase I/II study of ALX-0061 advances

Dec. 1, 2011

Japanese team synthesizes novel MMP-9 inhibitors

Nov. 30, 2011

FDA accepts Lodotra NDA for review

Nov. 30, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...